SAB Biotherapeutics, Inc. (SABS)
3.715
-0.08
(-1.98%)
USD |
NASDAQ |
Aug 31, 16:00
3.715
0.00 (0.00%)
After-Hours: 20:00
SAB Biotherapeutics 1 Year Total Returns (Daily) : 80.48% for Aug. 28, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 28, 2026 | 80.48% |
| August 27, 2026 | 85.38% |
| August 26, 2026 | 79.21% |
| August 25, 2026 | 72.01% |
| August 24, 2026 | 64.96% |
| August 21, 2026 | 83.94% |
| August 20, 2026 | 84.08% |
| August 19, 2026 | 89.00% |
| August 18, 2026 | 73.85% |
| August 17, 2026 | 69.82% |
| August 14, 2026 | 67.42% |
| August 13, 2026 | 74.42% |
| August 12, 2026 | 75.93% |
| August 11, 2026 | 86.41% |
| August 10, 2026 | 71.82% |
| August 07, 2026 | 74.89% |
| August 06, 2026 | 75.80% |
| August 05, 2026 | 63.91% |
| August 04, 2026 | 68.86% |
| August 03, 2026 | 69.96% |
| July 31, 2026 | 89.89% |
| July 30, 2026 | 57.52% |
| July 29, 2026 | 53.64% |
| July 28, 2026 | 36.36% |
| July 27, 2026 | 34.90% |
| Date | Value |
|---|---|
| July 24, 2026 | 35.00% |
| July 23, 2026 | 43.78% |
| July 22, 2026 | 37.16% |
| July 21, 2026 | 34.81% |
| July 20, 2026 | 36.58% |
| July 17, 2026 | 24.65% |
| July 16, 2026 | 31.36% |
| July 15, 2026 | 42.52% |
| July 14, 2026 | 33.83% |
| July 13, 2026 | 43.46% |
| July 10, 2026 | 52.79% |
| July 09, 2026 | 55.29% |
| July 08, 2026 | 46.12% |
| July 07, 2026 | 98.98% |
| July 06, 2026 | 127.9% |
| July 02, 2026 | 124.0% |
| July 01, 2026 | 120.5% |
| June 30, 2026 | 122.2% |
| June 29, 2026 | 130.8% |
| June 26, 2026 | 113.5% |
| June 25, 2026 | 112.6% |
| June 24, 2026 | 113.3% |
| June 23, 2026 | 119.9% |
| June 22, 2026 | 119.6% |
| June 18, 2026 | 124.7% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 280.1% |
| Oncolytics Biotech, Inc. | -19.94% |
| Sangamo Therapeutics, Inc. | -70.35% |
| Sarepta Therapeutics, Inc. | 13.74% |
| Anixa Biosciences, Inc. | 15.61% |